Recent Advances and Insights in Weight Management, Healthy Living, and Healthy Eating – December 2025

1. Oral GLP-1 Medications: A Breakthrough in Weight Management

On December 22, 2025, Novo Nordisk's Wegovy® oral semaglutide pill (25 mg daily) received FDA approval as the first oral GLP-1 receptor agonist for weight management. Data from the OASIS 4 trial showed that participants lost an average of 16.6% of their body weight over 64 weeks. Notably, approximately one in three participants achieved 20% or greater weight loss, comparable to the injectable form of Wegovy (2.4 mg weekly). The pill form promises improved accessibility and convenience by eliminating the need for injections, with a US launch expected in early January 2026.
These GLP-1 medications mimic the natural hormone GLP-1 to slow digestion and increase satiety. Emerging oral formulations from other companies, such as orforglipron, show promising results with up to 12.4% average body weight loss at highest doses.

2. Impact of Plant-Based Diet Quality on Cardiovascular Disease Risk

A large-scale study published December 14, 2025, followed 63,835 adults for an average of 9.1 years, revealing that diets rich in high-quality, minimally processed plant foods reduce cardiovascular disease (CVD) risk by about 40% compared to diets with fewer nutritious plant foods. Conversely, consuming substantial amounts of ultra-processed plant-based foods (such as industrial breads, commercial soups, and ready-made dishes) was linked to approximately 40% higher CVD risk compared to diets that included minimally processed plant foods and more animal-based products. This highlights that the degree of processing and nutritional quality have a larger health impact than simply eating plant versus animal foods.

3. Expanding Weight Management Market Driven by Technology and Preventive Health Focus

The global weight management market is expanding at a compound annual growth rate (CAGR) of 7.6% through 2030, fueled by increasing digital adoption and a stronger emphasis on preventive health. This market growth reflects rising consumer engagement with weight management technologies, apps, and services intended to support healthier lifestyles.

4. Improvements in Global Access to Essential Health Services

The World Bank's December 16, 2025, update to the World Development Indicators shows measurable gains in the Universal Health Coverage (UHC) Service Coverage Index worldwide. These improvements include better access to TB incidence monitoring and treatment, reductions in undernourishment, and increased vitamin A supplementation, helping provide a comprehensive snapshot of global nutrition and health advancement.

Summary: The past week has been marked by significant progress in medical treatment for obesity with the FDA approval of the first oral GLP-1 medication yielding substantial weight loss results. Simultaneously, evidence continues to support the critical role of diet quality over mere dietary type for cardiovascular health, emphasizing the harm of ultra-processed foods. The weight management field is growing robustly, underpinned by digital health innovations and preventive approaches. On a global scale, improved health service coverage offers optimism for tackling nutrition-related chronic diseases.

Sources

• https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916472
• https://www.brgeneral.org/news-blog/big-news-small-pill-oral-glp-1-meds-are-coming
• https://www.sciencedaily.com/releases/2025/12/251214100928.htm
• https://www.globenewswire.com/news-release/2025/12/24/3210271/0/en/Weight-Management-Market-Outlook-to-2030-7-6-CAGR-as-Digital-Adoption-Rises-and-Preventive-Health-Focus-Strengthens-Says-Mordor-Intelligence.html
• https://blogs.worldbank.org/en/opendata/world-development-indicators--december-2025-update--new-data-on-